Skip to content

BioNeMo vs Isomorphic Labs

A side-by-side comparison of BioNeMo and Isomorphic Labs, two Science tools, drawn from Ignaite's continuously-verified listings.

Compared from listings verified as of

BioNeMo

Science

NVIDIA's development platform for AI drug discovery.

View BioNeMo

Isomorphic Labs

Science

AI-first drug design built on AlphaFold for pharma R&D.

View Isomorphic Labs

At a glance

Feature comparison of BioNeMo and Isomorphic Labs
AttributeBioNeMoIsomorphic Labs
CategoryScienceScience
Pricing (differs)FREEMIUMPAID
License (differs)Open coreProprietary
Deployment (differs)HybridCloud
Platforms (differs)API, LinuxWeb
Model support (differs)Self-contained (on-device)
Vendor (differs)NVIDIAIsomorphic Labs

The honest brief

BioNeMo

GPU-optimized recipes claim ~2x faster biofoundation-model training and ~6x faster inference versus unoptimized pipelines.

  • Open-source framework (Apache-2.0)
  • Prebuilt models for protein and molecule tasks
  • NIM microservices for production deployment
  • Bundles datasets and training recipes
  • Requires NVIDIA GPUs
  • Steep learning curve for non-ML scientists
  • Production microservices are paid

Isomorphic Labs

Direct lineage to Nobel-winning AlphaFold plus Alphabet backing — few AI-drug shops pair that model pedigree with deep-pocket pharma partnerships.

  • AlphaFold-derived design models
  • Alphabet-backed capital
  • Top-pharma partnerships
  • Nobel-laureate leadership
  • Pharma partnerships only
  • No public product or API
  • No approved drug yet
  • Opaque pricing